Today’s AI Top Pick: TEM

TEM is the only candidate in the pool, but it earns the pick on its own merits rather than by default. The multi-timeframe forecast is genuinely aligned to the upside on the horizons that matter: 1d fc_short +10.8%, fc_mid +41.6%, fc_long +31.11%; 1wk fc_short +14.97%, fc_mid +40.13%, fc_long +32.72%. The 1h/4h short-term forecasts are slightly negative (-0.55%/-0.51%), which is actually helpful — it tells us we're not chasing an extended intraday spike, and the daily/weekly models still project a large upward re-rating. Bullish probability of 1.0 and near_term_bullish=1 confirm model conviction. The entry location is excellent, not stretched. Price is at $47.47, sitting at just 3.47% of the 21-bar daily range and 4.35% of the 4h range, with a -22.94% drawdown from the 21-bar daily high. This is a beaten-down name near the low of its range, exactly the profile the framework rewards (drawdown acceptable, position low). RSI 38.16 confirms it's oversold but not capitulating. Short float of 31.67% is enormous — any positive catalyst can force a violent squeeze, and the model_backed_squeeze lens is specifically designed to catch this setup. The news backdrop is a clear positive catalyst rather than a landmine. The 7/23 headline about Tempus making a $1.5B bet to corner the cancer-test market (Personalis-related) and the 7/22 launch of OneOme Pharmacogenomics testing are both offensive, expansionary moves — not dilution, not guidance cuts, not litigation. Sales growth of +69.82% YoY and 62.22% gross margin support the growth narrative; analyst recom 2.16 and targetUpsidePct +41.8% line up with the model's mid/long forecasts. Fundamentals score is -1 because of negative margins (opMargin -18.75%, profitMargin -22.2%), ROE -81.58%, and debtEq 3.17 — real risks, but they're already priced in given the -20.47% YTD and -23.12% 1-yr performance. TODAY is the right entry because the setup combines (a) an oversold, low-in-range price, (b) a fresh positive M&A/product catalyst just hitting the tape, (c) a 31.67% short float primed to squeeze, and (d) daily and weekly model forecasts of +30–40%. Waiting risks missing the reflex move off the range low.